{"name":"NeoStrata Company, Inc.","slug":"neostrata-company-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Desonide Cream","genericName":"Desonide Cream","slug":"desonide-cream","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)","status":"phase_3"},{"name":"calcipotriol","genericName":"calcipotriol","slug":"calcipotriol","indication":"Plaque psoriasis","status":"marketed"}]}],"pipeline":[{"name":"Desonide Cream","genericName":"Desonide Cream","slug":"desonide-cream","phase":"phase_3","mechanism":"Desonide is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)"],"catalyst":""},{"name":"calcipotriol","genericName":"calcipotriol","slug":"calcipotriol","phase":"marketed","mechanism":"Vitamin D3 receptor","indications":["Plaque psoriasis","Scalp psoriasis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTDRMNGpncTdHdmpPWHBuaW9LZnQxbFVHelJVRzR1RTZQX1RaandwOGYwWHJjNFdqWWNLeXk5V2U4MjI0OTZadFhJMXpKV0F6RGFwczFZd2RWZUlDeDd2VVpqczFtUWRrRVFGUm5kWEhPZlpMcFF1aVctbTZvdUoxNG4ydHEzWE5hQ0twaXpjOGxoMlJVRE5RcFB4b0xITlRxZVRPWDV0cGZJVFlkekx1M2xGQXQwa1VxdzgtMzh2YWRiVTQyeTVZbE9OeC1RYnNrdkE?oc=5","date":"2017-07-17","type":"earnings","source":"Pharmaceutical Technology","summary":"Health and wealth: the ten biggest pharmaceutical companies by revenue - Pharmaceutical Technology","headline":"Health and wealth: the ten biggest pharmaceutical companies by revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTURUMDk2ZzFfUUZyVWNGRHE3NzFITndZMkJLcEswRDVEMVp4bEhNUlp4THU5Uy13VVdnSTlGX0NUWDItVG91a1Q4MUFZNFktMlM4WUkzWm53RVZYOFc5WVk1UkkySDk3VnE2ZmZnTE9JbGx2amI1UEw5OE9IZ1ZCS19OVkc3ak45VENv?oc=5","date":"2010-02-26","type":"pipeline","source":"Best Health Magazine Canada","summary":"The truth about pharmaceutical-grade skincare - Best Health Magazine Canada","headline":"The truth about pharmaceutical-grade skincare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPcXpCTHVvRHBDRUNzRDdvMUFlUUR3Z0g2MG5WSHEtVDlnalJzeEl0YTRnSmFOOVRtNC1RcTNfdE5rTXkwSmNyLVVmajhQZGFyUDFxWVctTWp6NlppV3Z4aXktMmVvRG9idkh5aVR2SkFNWlVQdlFhaWZJTFk5QzJkclJsSVRLVTZJTnc?oc=5","date":"2000-11-06","type":"patent","source":"Happi | Household And Personal Products Industry","summary":"L’Oreal Settles Pending Patent Infringement Litigation With NeoStrata - Happi | Household And Personal Products Industry","headline":"L’Oreal Settles Pending Patent Infringement Litigation With NeoStrata - Happi | Household And Personal Products Industry","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}